-
A Study In Adults With Moderate To Severe Dermatomyositis
Scottsdale/Phoenix, AZ
A Study looking at Investigational drug and Placebo administered to adult Patients with moderate to severe Dermatomyositis
-
A Phase 3 Study To Investigate The Efficacy And Safety Of Brepocitinib In Adults With Dermatomyositis
Scottsdale/Phoenix, AZ; Jacksonville, FL; Rochester, MN
The purpose of this study is to determine the effetiveness and safety of brepocitinib (a tyrosine kinase [TYK] 2/Janus kinase [JAK] 1 inhibitor) in patients with dermatomyositis.
-
A Study To Evaluate The Effectiveness, Safety And Tolerability Of PF-06823859 In Adults With Moderate-to-Severe Dermatomyositis
Jacksonville, FL
The purpose of this study is to evaluate the investigational drug PF-06823859 and a placebo administered to adult pPatients with moderate-to- severe Dermatomyositis.
-
An Extension Study For Participants Who Have Completed The Treatment Period Of A Qualifying Parent Study
Scottsdale/Phoenix, AZ; Jacksonville, FL
The purpose of this research study is to evaluate the long-term safety, and tolerability of PF-06823859 study drug in adult participants with Dermatomyositis (DM) from a qualifying study.
-
Tocilizumab In The Treatment Of Refractory Polymyositis And Dermatomyositis
Rochester, MN
The purpose of this multi-center pilot study is to determine if the drug tocilizumab (Actemra) is effective in the treatment of patients with refractory adult polymyositis (PM) and dermatomyositis (DM).
-
A Study To Understand How The Study Medicine (PF-06823859) Works In People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) And Polymyositis (PM)]
Scottsdale/Phoenix, AZ; Jacksonville, FL
The purpose of this study is to evaluate the effectiveness of PF-06823859 in reducing muscle symptoms in adult participants with active Dermatomyositis (DM) and adult participants with active Polymyositis (PM).